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feedback interventions to increase the uptake of
evidence-based transfusion practice: an
intervention development protocol
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Abstract
Background: Audits of blood transfusion demonstrate around 20% transfusions are outside national
recommendations and guidelines. Audit and feedback is a widely used quality improvement intervention but
effects on clinical practice are variable, suggesting potential for enhancement. Behavioural theory, theoretical
frameworks of behaviour change and behaviour change techniques provide systematic processes to enhance
intervention. This study is part of a larger programme of work to promote the uptake of evidence-based transfusion
practice.
Objectives: The objectives of this study are to design two theoretically enhanced audit and feedback interventions;
one focused on content and one on delivery, and investigate the feasibility and acceptability.
Methods: Study A (Content): A coding framework based on current evidence regarding audit and feedback, and
behaviour change theory and frameworks will be developed and applied as part of a structured content analysis to
specify the key components of existing feedback documents. Prototype feedback documents with enhanced
content and also a protocol, describing principles for enhancing feedback content, will be developed. Study B
(Delivery): Individual semi-structured interviews with healthcare professionals and observations of team meetings in
four hospitals will be used to specify, and identify views about, current audit and feedback practice. Interviews will
be based on a topic guide developed using the Theoretical Domains Framework and the Consolidated Framework
for Implementation Research. Analysis of transcripts based on these frameworks will form the evidence base for
developing a protocol describing an enhanced intervention that focuses on feedback delivery. Study C (Feasibility
and Acceptability): Enhanced interventions will be piloted in four hospitals. Semi-structured interviews, questionnaires
and observations will be used to assess feasibility and acceptability.
Discussion: This intervention development work reflects the UK Medical Research Council’s guidance on development
of complex interventions, which emphasises the importance of a robust theoretical basis for intervention design and
recommends systematic assessment of feasibility and acceptability prior to taking interventions to evaluation in a
full-scale randomised study. The work-up includes specification of current practice so that, in the trials to be conducted
later in this programme, there will be a clear distinction between the control (usual practice) conditions and the
interventions to be evaluated.
Keywords: Audit and feedback, Blood transfusion, Implementation, Health services research, Study protocol, Health
professional behaviour change
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Background
Blood components are scarce and costly resources that
are used in almost every area of hospital practice. How-
ever, unnecessary blood transfusion is associated with
negative consequences and presents an unnecessary risk
to patients. Examples of risk are transfusion infections,
acute lung injury, and circulatory overload, which are as-
sociated with increased morbidity and mortality [1,2].
National guidelines [3] provide a framework for defining
unnecessary transfusions. For example, in the case of red
cell transfusion, by specifying the pre-transfusion haemo-
globin concentrations at which it is appropriate to transfuse
a patient in different clinical settings [4-6]. Similar evidence
to inform recommendations applies for other blood
components [7].
Despite concerns about risks of transfusion [2], the
practice of giving unnecessary transfusions persists. NHS
Blood and Transplant (NHSBT) manage the provision of
blood components for England and North Wales, and
promote appropriate transfusion practice through na-
tional audits on transfusion practice. Regional and na-
tional audits have consistently demonstrated that at least
20% of the use of different blood components (i.e., red
blood cells, plasma, and platelets) falls outside national
guideline recommendations [8,5]. There is thus the poten-
tial to save costs without compromising patient outcomes
by reducing the number of unnecessary transfusions.
Most quality improvement activity in blood transfu-
sion has focused on improving safety of donated blood
for transfusion. Increasing attention is now focusing on
improving blood use by clinicians so that transfusion
practice is more consistent with evidence-based recom-
mendations [5]. This protocol describes the first stage of
a programme of research that aims to specify current
feedback practice and then develop and evaluate enhanced
methods to promote the uptake of evidence-based trans-
fusion guidelines and reduce the unnecessary use of blood
components.
Implementation science has played a central role in
developing and evaluating interventions that are designed
to address the evidence-practice gap by targeting behav-
iour change amongst healthcare professionals within the
organisations and systems in which they work [9,10].
Audit and feedback (A&F) is a widely used intervention
to improve the quality of health care, including blood
transfusion practice through the NHSBT national audit
programme. It is defined as any summary of clinical per-
formance of healthcare over a specified period of time,
to provide healthcare professionals with data on per-
formance [11]. There is evidence that A&F interven-
tions deliver modest, variable, but worthwhile effects,
with the recent Cochrane review [11] indicating an
overall 4.3% (IQR 0.5% to 16%) increase in compliance
with desired practice as a result of A&F in a range of
clinical areas. The review investigated this heterogeneity
and identified that A&F is more effective at changing
practice when baseline performance is low, feedback is
provided more than once, is delivered by a colleague or
supervisor, is delivered in both verbal and written formats,
and includes explicit targets and action plans. These find-
ings contribute to the growing understanding of how A&F
works by identifying its active ingredients and highlighting
its potential mechanisms of action [12].
It has been argued that theory and emerging evidence
about how best to design (and not to design) A&F inter-
ventions should be incorporated into the development
of future A&F interventions in order to identify how and
when A&F works best, as such theoretical underpinnings
are rarely reported in reviews of behavioural interventions
[12-14]. Theories of behaviour change, used effectively
in a wide variety of applied health research to explain
and change behaviour [15,10], hold the potential to clar-
ify mechanisms of action and to provide generalisable
frameworks for understanding how interventions work
[16,17]. They also offer practical and systematic methods
to guide intervention development in relation to clinical
practice [18].
However, there are a large number of behaviour change
theories, often overlapping in their concepts, making it
difficult to choose the most relevant to apply to a behav-
iour [19]. To make theory more accessible, the Theoretical
Domains Framework (TDF) [20] was developed, in which
128 constructs (key concepts) from 33 behaviour change
theories were grouped into 12 theoretical domains includ-
ing behavioural regulation, social influences, and beliefs
about consequences. The framework has been used in a
number of contexts within implementation research, and
can be used to explore implementation problems, design
interventions and understand behaviour change processes
[19,21-26]. For example, the TDF has been applied to sys-
tematically identify the theoretical domains of greatest
relevance to explaining blood transfusion practice in in-
tensive care units, with ‘behavioural regulation’ identified
as a key domain influencing practice [26]. Behavioural
regulation, defined as the processes of goal selection and
goal achievement, involves the techniques of goal setting,
monitoring, and providing feedback [27]. Control Theory
[27] is a theory of behavioural regulation which posits
that individuals manage their behaviour by knowing
what they want to do or achieve (i.e. setting a goal or
standard), trying to do it (i.e. action), monitoring the be-
haviour (i.e. audit), assessing whether they are making
progress towards the goal (i.e. feedback, which informs
as to the nature and extent of any discrepancy between
behaviour and goals), and adapting what they do in light
of the feedback (i.e. action planning). We propose that
organisations may also use these techniques to regulate
the behaviour of individuals working in them.
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Theories of behaviour change are potentially useful for
optimising A&F by pointing to behaviour change tech-
niques that may augment the effectiveness of receiving
feedback about clinical practice [14,28]. The recent de-
velopment of a comprehensive taxonomy of behaviour
change techniques (BCTs) [29] provides a replicable and
systematic method for identifying and describing inter-
vention components that are consistent with Control
Theory and that may enhance practice. BCTs are defined
as the “observable, replicable and irreducible components
of an intervention designed to alter or redirect causal pro-
cesses that regulate behaviour” (i.e. the proposed ‘active
ingredients’) [29]. The taxonomy includes BCTs that en-
compass strategies proposed in Control Theory; for in-
stance, ‘goal setting,’ ‘feedback on behaviour,’ ‘discrepancy
between behaviour and goal,’ and ‘action planning’ [29].
The current study uses Control Theory and the BCT
Taxonomy to specify current A&F practice in blood
transfusion and to inform the design of enhanced A&F
interventions.
BCTs applied at the level of the individual, and use of
the TDF to identify potential barriers to change individ-
uals’ behaviour, may not be the only approaches to im-
proving transfusion practice or optimising A&F in the
hospital context. Behaviour change within a healthcare
setting is a complex process, and due to the multi-level
nature of healthcare organisations, elements of change
in response to feedback may be outside the control of
any individual healthcare professional [12]. Ferlie and
Shortell [30] propose four levels of change that should
be considered in order to maximise the chance of suc-
cess: individual, group or team, overall organisation, and
wider system or environment. Developing this idea, the
Consolidated Framework for Implementation Research
(CFIR) [31] provides a framework for identifying what
works where and why across different organisational levels
within multiple settings.
Based on the considerations outlined above, the current
study is designed to gather evidence to inform the en-
hancement of A&F practice, in ways that permit replication
and continuing enhancement of A&F as an intervention to
support clinical behaviour change in transfusion practice.
This study is the first in the AFFINITIE Programme,
funded by the UK National Institute of Health Research,
which comprises four interrelated ‘workstreams’ to be
conducted over five years (Figure 1).
The workstream structure draws on the systematic
methodological approach recommended in the UK Med-
ical Research Council (MRC) guidance for developing
and evaluating complex interventions [32], which pro-
vides a systematic approach to this work: intervention
development, feasibility and piloting, evaluation, and
implementation.
The current paper presents the study protocol for
workstream one (WS1: Intervention development and
piloting), which addresses the intervention development,
feasibility, and piloting components of the MRC frame-
work. Two enhanced interventions will be designed and
Workstream 1 (WS1: Intervention development and piloting)
Development, piloting and refinement of two enhanced feedback 
interventions: ‘enhanced content’ and ‘enhanced delivery’
Workstream 2 (WS2: Evaluation)
Cluster-randomised trial to evaluate effectiveness of enhanced 
feedback interventions compared with usual feedback, with a decision 
analytic modelling analysis for cost-effectiveness
Workstream 3 (WS3: Fidelity)
A parallel process evaluation to investigate fidelity of the interventions 
as delivered, received and enacted
Workstream 4 (WS4: Implementation)
Development of general recommendations and tools
Figure 1 AFFINITIE Programme work streams overview.
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assessed for feasibility and acceptability. Theory will be
applied to two key facets of A&F: the content of docu-
ments providing feedback and the processes of feedback
delivery (including how it is delivered and to whom it is
delivered). The interventions developed during WS1
(Intervention development and piloting), will be evaluated
in workstream two (WS2: Evaluation) in two replicated
2 × 2 factorial cluster randomised control trials (C-RCT)
in the context of a National Comparative Audit of blood
transfusion. The development of these two interventions,
one focusing on feedback content and the other focusing
on feedback delivery, will thus be informed by theoretical
frameworks of clinical behaviour change applied at the in-
dividual, team, and organisational levels. Development will
also be informed by the early components of this study
that will generate an evidence base from past A&F prac-
tice and from multi-method studies in the hospital con-
text. Clinical and behaviour change experts will have input
into the enhancement of these interventions, which will
additionally be informed by the systematic collection and
analysis of feasibility and acceptability data.
The aims of WS1 (Intervention development and piloting)
are to:
1. Use the evidence base relating to A&F and
behaviour change to describe current A&F practice
relating to blood transfusion, focusing on two
aspects of current practice: content and delivery.
2. Apply systematic methods and the evidence about
current practice to develop, pilot and refine two
feedback interventions focusing on enhancing
content and delivery of feedback.
Methods
Overview WS1: Intervention development and piloting
WS1 (Intervention development and piloting) consists of
three sub-studies: study A ‘Investigation of content’; study
B ‘Investigation of delivery’; and study C ‘Investigation of
feasibility and acceptability.’
Study A: investigation of content
Objectives
1. To describe how A&F for blood transfusion practice
is currently operationalised and to analyse the
components of existing feedback documents.
2. To systematically identify methods by which the
content of current feedback may be enhanced.
3. To develop an intervention guidance document and
training materials for preparing enhanced feedback
content.
4. To prepare a prototype of a feedback document with
enhanced content to be delivered as part of study C
(Feasibility and acceptability).
Design
A structured content analysis of the key components of
existing feedback documents, based on relevant evidence
[11], current theories, and frameworks for understanding
behaviour change.
Materials
Since its inception in 2002, the UK NHSBT has con-
ducted a total of 19 A&F cycles examining different as-
pects of blood transfusion practice. An A&F cycle
typically has a set of pre-specified ‘audit standards’ (e.g. a
pre-transfusion haemoglobin reading is taken in 100% of
patients prior to transfusion). These standards are often
based on existing, relevant clinical guidelines and evi-
dence, and represent the specific transfusion-related be-
haviours being audited. Feedback recipients’ behaviour
will be compared against these standards. A&F cycles in
the NHSBT audit generally consist of three distinct
stages: Pre-Audit, in which hospitals are invited to par-
ticipate in the audit; Audit, during which audit data are
collected; and Feedback, in which results from the audit
are fed back to the hospitals. Different types of docu-
ments are utilised within each of these stages, and this
study will specifically examine documents from the feed-
back stage (e.g. written reports, action planning tem-
plates, or PowerPoint presentations) (See Additional file
1 for an example of a current blood transfusion feedback
report). To examine how current A&F is operationalised
in the context of blood transfusion, such documents
from previously conducted A&F cycles will be obtained
from NHSBT and systematically examined using a com-
prehensive coding framework (see below).
Procedure
Sampling of A&F cycles
Existing A&F cycles conducted by NHSBT will be sam-
pled by two members of the research team in consult-
ation with the clinical lead on the research team if they
are:
1. a national comparative audit (i.e. not local or
regional audit);
2. examine behaviours related to the decision to
transfuse (i.e. not behaviours related to blood quality
or safety of administration);
3. represent current A&F practice (i.e. conducted
within ≤10 years of the present study);
4. for aspects of blood transfusion practice that have
been audited more than once, the included cycle, be
the most-recently conducted version (i.e. the most
recent re-audit, not the original audit);
5. have explicitly stated audit standards (i.e. target
behaviours).
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Inter-rater sampling agreement amongst reviewers
will be assessed using Cohen’s Kappa, with a minimum
Kappa value of 0.75 indicating an acceptable level of
agreement [33].
Development and application of the coding framework
To conduct the structured content analysis, a compre-
hensive coding framework will be developed and applied
to describe the characteristics and components of the
feedback documents. An established, reliable taxonomy
of 93 BCTs [29] will be embedded within the coding
framework to enable specification of BCTs comprising
feedback content. Data will be extracted on the number
and frequency of different BCTs identified within each
document. The extent to which BCTs consistent with
Control Theory [27] (e.g. ‘goal-setting,’ ‘discrepancy be-
tween current behaviour and goal’) are included in current
feedback documents will be examined.
The coding framework will also include items to exam-
ine the behavioural specificity of the audit standards. Be-
havioural specificity will be examined according to the
TACT Principal: Target, Action, Context, and Timeframe
[34]. For instance, the behaviour ‘referring patients with
back pain for lumbo-sacral spine x-ray’ may be specified
using TACT as follows: Target, ‘patient’; Action, ‘referral’;
Context, ‘clinical condition (back pain)’; and Timeframe,
‘(implicitly) during the consultation’ [35]. We propose to
extend the TACT principle to additionally specify the
audit standards in terms of the ‘Actor,’ that is, who is re-
sponsible for performing the behaviour (e.g. physicians).
The percentage of audit standards in which the behav-
ioural Target, Action, Context, Timeframe, and Actor is
clearly specified will be examined. The extent to which
audit standards are specified in the same manner across
different documents pertaining to the same A&F cycle will
be examined.
Findings from the Cochrane review of A&F [11] re-
garding the effectiveness of different A&F strategies will
further inform the development of coding framework
items for assessing the characteristics of feedback con-
tent. These will include: feedback provider and recipient;
level of data fed back (i.e. group vs individual); mode of
delivery (i.e. written vs graphical); whether or not the
feedback item is explicitly related to an audit standard;
recipients’ baseline behaviour and actual behaviour or at-
tainment level; whether normative information is provided
about others’ behaviour; whether an explicit comparison
is made between the recipients’ behaviour and a compara-
tor; if yes, the nature of the comparator (e.g. others, clin-
ical guidelines or standards, past behaviour); and whether
or not feedback is presented in conjunction with action
planning and/or goal-setting. The percentage of feedback
items explicitly related to an audit standard will be
computed. The TACT principle [34] will be applied to
examine the extent of behavioural specificity of each
feedback item, as well as any accompanying action plans
or goals set in response to feedback.
It is important that feedback documents are presented
in a clear and comprehensible manner if their content is
to be accessible and understood. Therefore, the layout and
structure of documents will be examined using items from
the Suitability of Assessment Materials framework [36], a
validated framework for assessing the suitability of printed
health information materials in terms of their layout, liter-
acy demand, typography, and graphics.
The feedback documents will be analysed using the cod-
ing framework by two members of the research team in
consultation with the research team’s clinical lead. Inter-
rater coding reliability will be assessed using Cohen’s Kappa
or percentage agreement as appropriate, with a desired
minimum Kappa value of 0.75 or 75% agreement; indicat-
ing an acceptable level of agreement [33].
Synthesis and intervention development
Possible enhancements of feedback content will be con-
sidered concurrently with coding and this process will
be conducted in two steps. First, the current content of
feedback documents will be specified in terms of the
BCTs that are included and the level of behavioural spe-
cification. Second, members of the research team will
examine this specification to identify aspects of the doc-
uments that may be re-written or enhanced. This step
will be guided by theory, such as Control Theory [27],
and principles such as TACT-A. For example, if it is
found that only a narrow range of BCTs consistent with
Control Theory are currently featured in feedback docu-
ments, enhancement could include re-writing the feed-
back documents so that the omitted BCTs consistent
with Control Theory are delivered (See Additional file 2
for an example illustrating the potential enhancement of
feedback content to increase the delivery of BCTs con-
sistent with Control Theory). Similarly, if for instance it
is found that the timeframe is rarely or poorly specified
in the audit standards, standards will in turn be re-
written to clarify and increase behavioural specificity in
terms of timeframe (e.g. specifying whether the behav-
iour is to be performed pre- or post-transfusion).
The identified enhancements will be integrated into a
prototype set of feedback documents (templates) for de-
livering enhanced content. Such identified methods for
enhancing feedback content and the resulting, theoretic-
ally enhanced prototype documents will be discussed
with a multi-disciplinary consensus panel (comprising
three or four experts in behaviour change, three or four
blood transfusion clinicians, a methodologist from the
AFFINITIE Trials team, a representative from the National
Comparative Audit, and a patient representative), in order
to ensure that the suggestions are theoretically appropriate,
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acceptable from a clinician’s perspective, feasible from
the perspective of trial design, and appropriate for the
context at which they are aimed. Following this, the
proposed interventions will be revised and refined as re-
quired. It is possible that analysis of data from study B
(Delivery; see below) will also inform the development
of this intervention.
Anticipated outputs
A guidance document (i.e. intervention protocol) and
accompanying training materials describing the princi-
ples of analysing and writing enhanced feedback content
and a prototype set of feedback documents with enhanced
content that will be piloted in study C (Feasibility and
acceptability).
Study B: investigation of delivery
Objectives
This study will be conducted in parallel to study A (Content),
with three main objectives:
1. Identify how delivery of feedback is currently
operationalised in practice in the hospital context,
and how this could be enhanced.
2. Identify who currently receives feedback (i.e. types of
healthcare professionals and organisational levels),
and who should receive feedback.
3. Develop an intervention protocol for enhancing the
delivery of feedback to all relevant staff (identified
from objective two), along with practical guidance
for clinical teams on how to respond as a team to
feedback, using appropriate behavioural strategies.
Design
The study will use a case study design involving semi-
structured interviews and observations of transfusion re-
lated meetings at four hospital sites in England.
Participants and sampling
Sampling of sites
Potential hospitals and Trusts (i.e. organisational units
within the National Health System in which hospitals or
clinics are nested) will be identified through consultation
with the clinical lead on the research team, and will be
selected from those who take part in the NHSBT na-
tional comparative audits of blood transfusion. A pur-
posive sampling strategy will be used to identify hospital
sites that are diverse in their infrastructure and level of
resources (e.g. role of Transfusion Practitioner) and to
include at least one teaching and one district hospital.
These hospitals will be approached by a clinical member
of the research team through their respective Trust Re-
search and Development (R&D) Offices, with the first
four to respond to be selected for study B (Delivery),
once diversity across the hospitals has been established,
and the remaining four to then be approached for the sub-
sequent study C (Feasibility and acceptability: outlined
below).
Sampling of participants
A purposive sampling strategy will be used to identify
five to eight healthcare professionals within each of the
four study B (Delivery) hospitals who reflect the range of
individuals involved in, or with influence over, transfusion
decisions, or who are responsible for following practice
recommendations (e.g. clinical leads, senior clinicians,
haematologists, hospital transfusion committee mem-
bers, junior doctors, regional transfusion professionals).
Diversity of the sample will be monitored to ensure that
interviews are conducted with a representative range of
healthcare professionals from different organisational
levels, and to establish how widely the current feedback
is disseminated to and discussed by these professional
groupings.
During R&D approval, a local transfusion contact will
be identified to help identify potential interviewees and
transfusion related meetings to observe. Details of rele-
vant meeting to observe will determine the potential
dates for the research visit to the site. Potential interview
participants will be sent a recruitment email with an
accompanying information sheet and consent form, to
enquire if they are willing to participate in an inter-
view, following informed consent an interview will be
scheduled.
It is anticipated that there may be circumstances in
which participants who are originally scheduled for
interview are not available on the day due to the nature
of their clinical responsibilities, and also that the list pro-
vided from the clinical contact would not be exhaustive of
the range of individuals involved in transfusion decisions.
Therefore, a second opportunistic recruitment strategy
will be employed whereby additional eligible healthcare
professionals who are present at the hospital during the
data collection period will be given the opportunity to vol-
unteer for interview, with the same process of informed
consent applied as to those approached ahead of the visit.
Materials
Two sets of study materials will be developed: interview
topic guide and observation sheet:
1. An interview topic guide will be developed to elicit
information using constructs from the TDF [20] and
the CFIR [31]. As the interviewees will be from a
range of professional roles and may vary in their
previous involvement with A&F, the topic guide will
begin with some general questions about transfusion
decision making, and awareness of current A&F
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processes. This will help to identify individuals who
are involved in the transfusion decision-making
process but who do not currently receive feedback,
and may inform the potential target groups for
enhanced interventions. The topic guide will include
questions about Ferlie and Shortell’s [30] four levels
of change for improving quality: the individual,
group or team, organisation, and the larger system
or environment. A wide range of potential methods
of delivery and their acceptability will be explored in
the interview. To explore the validity of the topic
guide prior to conducting interviews, items will be
double coded into TDF domains and CFIR
constructs by two researchers. Percentage agreement
will be calculated as an indication of inter-rater
reliability and consensus on coding will be achieved
through discussion between coders. The schedule
will be piloted with healthcare professionals to allow
refinements of question wording and delivery.
2. If possible, we will observe key meetings
disseminating audit feedback to identify
organisational feedback processes. An observation
sheet will be developed to record the observations.
This will focus on elements such as the structure,
function (e.g., behavioural regulation, social
influence, information provision), group processes,
body language, and the content of A&F discussion
within the key meetings.
Procedure
1. One-to-one, semi-structured interviews, based upon
the topic guide and lasting a maximum of one hour,
will be conducted face-to-face at the hospital at a
time convenient for the interviewee. Interviews will
be audio-recorded with permission.
2. Two researchers will attend each key meeting, with
the consent of the Chair, and use a tailored
observation sheet to record observations.
Analysis
1. Audio-recorded interviews will be transcribed
verbatim and anonymised. Interview text will be
coded into the relevant domains (TDF) and
constructs (CFIR), and, in the manner reported by
Patey et al. [25], the first transcript will be coded
concurrently by two researchers to develop a coding
strategy for subsequent transcripts. Subsequent
transcripts will be coded by one researcher, with
10% independently double coded. Cohen’s Kappa
will be calculated to assess whether the same
interview responses are coded into the same
domains or constructs, with a minimum Kappa
value of 0.75 indicating an acceptable level of
agreement [33]. Consensus will be reached through
discussion, with a third independent coder asked to
help resolve any outstanding disagreements. After
responses have been coded using the theoretical
frameworks, emerging themes within each domain
or construct will be identified across the transcripts.
The second coder will review the themes to verify
an accurate representation of interview content.
2. To complement the data collected in the interviews,
organisational feedback processes will be identified
from observational data, e.g., how feedback is
discussed between individuals and teams within the
meeting, and the potential group processes that
influence feedback and decision making. These
observations will allow researchers to explore
whether such meetings would be an appropriate
context in which enhanced feedback could be
delivered to hospitals, through identifying
individuals with key job roles and responsibilities
related to the A&F process, and observing how
these individuals could play a role in delivering
feedback during the enhanced interventions
(study C: Feasibility and acceptability).
Initially, each hospital will be analysed as a single case
study in order to understand the feedback processes
within the organisational structure. Findings from the
four sites will then be compared and contrasted using a
triangulation process [37,38] to identify common and
contrasting themes across hospitals and within health-
care professional roles.
Synthesis and intervention development
The constructs, domains and themes that emerge from
analyses of the interview transcripts and meeting observa-
tion will be used to identify ways in which the delivery
of feedback could be enhanced (See Additional file 2).
We have identified four potential approaches to enhan-
cing feedback delivery processes:
1. Improve the ‘reach’ of the feedback documents. For
example, if it is identified that key individuals
involved in transfusion decisions are not typically
receiving feedback from an A&F cycle (e.g. junior
doctors), this group could be targeted by the
enhanced delivery intervention.
2. Identify, from the interview data, key domains or
constructs that could be addressed by BCTs. For
example, if interviews identify that staff think
current blood use objectives are unrealistic (i.e., the
domain beliefs about capabilities), an enhanced
intervention may include support materials that
deliver the BCT, ‘review outcome goals,’ so that staff
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are able to work towards a goal that they feel is
achievable.
3. Incorporate direct suggestions by interview
participants. Discussion of the potential feedback
methods during the interviews will help identify
ways in which feedback processes could be
enhanced; e.g., through the development of targeted
action plans for clinical teams.
4. Identify, from analysis of the observational data from
the observed clinical team meetings, any potential
for enhancement; e.g., provision of support materials
focusing on group processes could facilitate the
dissemination of information and team-level discussion
of responses.
The identified enhancements from the interviews and
meeting observations will be integrated into an interven-
tion protocol and set of supporting documents. It is pos-
sible that analysis of data from study A (Content) will
inform the development of this intervention.
Anticipated outputs
An intervention protocol for enhancing the delivery of
feedback to relevant staff, along with practical guidance
and support materials for clinical teams on how to re-
spond as a team to feedback, using appropriate behav-
ioural strategies.
Study C: investigation of acceptability and feasibility
Objectives
1. Integrate the enhanced interventions that are
developed during study A (Content) and study B
(Delivery).
2. Deliver the enhanced intervention to a pilot sample
of four hospitals.
3. Assess the acceptability and feasibility of delivering
such enhancements.
Design
The study will use a mixed methods design involving semi-
structured interviews, observations and questionnaires
at four hospitals in England.
Participants and sampling
Sampling of sites
The four hospitals identified during recruitment for
study B (Delivery; see above) will be approached to par-
ticipate. The participating hospitals will receive both of
the developed interventions as part of an abbreviated
NHSBT audit.
Sampling of participants for interviews
Purposive sampling will be used to identify up to 10
healthcare professionals who received the enhanced inter-
ventions and are responsible for acting upon A&F and
making, or influencing, transfusion decisions. Potential
participants will be identified using the same procedure
outlined for study B (Delivery).
Participants for questionnaires
Questionnaires will be sent to a representative range of
healthcare professionals who are involved in decisions to
transfuse at each hospital. Participants will be identified
using a purposive sampling strategy, and with the help
of the contacts within each hospital.
Interventions and materials
Prototype versions of the two enhanced feedback inter-
ventions will be delivered to participants in the context
of a re-audit of a recently conducted national blood
transfusion A&F cycle. An interview topic guide will be
developed to focus on the acceptability and feasibility of
the enhanced interventions. Additionally, a brief ques-
tionnaire will be developed to assess acceptability of the
interventions.
Procedure
Semi-structured interviews following the delivery of the
enhanced feedback interventions will focus on how en-
hanced feedback is interpreted, whether it is discussed
within the clinical team and how this happens, whether
the team sets standards and develops team-level action
plans, as well as any unintended consequences of the re-
vised feedback (e.g. reduced motivation). These interviews
will be conducted face-to-face and will last a maximum of
one hour. Organised events or meetings where feedback is
discussed will be observed, and researchers will aim to
identify the group-level response to using the intervention
materials through discussion with the clinical teams dur-
ing this meeting. The brief acceptability questionnaire will
be administered to a range of healthcare professionals
who are involved in blood transfusion decisions within
each hospital. This phase of WS1 (Intervention develop-
ment and piloting) will also pilot data collection forms for
later elements of the programme, such as the additional
time and resources likely to be involved.
Analysis
One component of feasibility is the extent to which it is
possible to deliver the developed interventions as intended
within the target context. Therefore, feasibility will be
assessed by examining intervention fidelity in terms of
delivery, receipt, and enactment [39]. According to Bellg
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et al. [39], fidelity of delivery has been defined as the ex-
tent to which the intervention is delivered as intended;
receipt as the extent to which the intervention recipient
demonstrates understanding of the intervention and know-
ledge of, and ability to use, the skills or recommendations
learned in the intervention; and enactment as the extent
to which the intervention recipient performs intervention-
related behavioural skills and cognitive strategies in rele-
vant real-life settings as intended. Fidelity of delivery will
be assessed using a documentary analysis of the enhanced
intervention materials, such as the feedback documents
with enhanced content developed as part of study A
(content), and the delivery support materials developed
through study B (delivery). This analysis may include,
for instance, an assessment of the extent to which the
proposed methods of optimising the content of feedback
documents (i.e. by including BCTs consistent with Control
Theory or improving the behavioural specification of audit
standards) features in the resulting, developed interven-
tion materials. Fidelity of receipt and enactment will be
examined via a content analysis of the semi-structured
interview transcripts to assess the extent to which feed-
back has been acted upon, for instance, through develop-
ment of action plans to reduce any observed discrepancy.
Observations of organized events or meetings where feed-
back is discussed will provide an opportunity to objectively
verify receipt and delivery.
Acceptability will be assessed in terms of the interven-
tion recipients’ perceptions of the quality and usability
of the enhanced feedback, as well as the perceived bur-
den of the enhanced interventions. This will be exam-
ined using content analysis of interview transcripts and
by computing descriptive statistics from the question-
naire data. Qualitative and quantitative findings will be
compared and contrasted descriptively.
Anticipated outputs
Findings from this study will inform refinement (if required)
of intervention protocols for the two enhanced feedback
interventions, and recommendations on the delivery of
the interventions in a trial context. Final versions of the
intervention protocols will be adopted by the AFFINITIE
trials team.
Ethics
Study A (Content) did not require ethical approval.
Study B (Delivery) was approved by the Ethics Committee
of City University London in October 2013 (Ref: Staff/13-
14/09). Research & Development approval has also been
obtained from all participating hospitals in study B. Ethical
and R&D approvals will be sought for study C (Feasibility
and acceptability) once sufficient detail about the enhance-
ments has been developed.
Study status
Study A (Content)
Currently (Start of 2014) the A&F cycles and documents
have been obtained from the NCA and are being sampled
for inclusion. The coding framework is being developed
and piloted on a sub-sample of feedback documents. Four
healthcare professionals involved in blood transfusion,
three experts in behaviour change, and a lay PPI member
have been recruited for the intervention validation con-
sensus panel.
Study B (Delivery)
The interview topic guide has been developed and vali-
dated. Four participating hospitals have been recruited,
and interviews with up to eight members of staff have
been completed at two of these hospitals. Analysis of
interview transcripts and feedback documents to inform
intervention development has not yet commenced.
Study C (Feasibility and acceptability)
Recruitment of potential hospitals to participate in the
piloting and the feasibility and acceptability assessments
of the development interventions is currently underway.
Discussion
The AFFINITIE programme aims to develop and evalu-
ate theoretically enhanced A&F interventions to promote
evidence-based transfusion practice and reduce unneces-
sary use of blood components. Workstream one (Inter-
vention development and piloting) aims to identify how
A&F is currently operationalised in the context of blood
transfusion and to develop, pilot, and refine two enhanced
feedback interventions, focusing on the content and pro-
cesses around delivery of feedback, which will be evaluated
in subsequent workstreams. Workstream one (Intervention
development and piloting) will apply evidence [11], behav-
ioural theory (Control Theory [27]), theoretical frame-
works TDF [20], and CFIR [31], and BCTs [29] to develop
the enhanced interventions and to pilot these to assess the
feasibility and acceptability of the enhancements.
Clear specification of current A&F practice in the con-
text of NHSBT’s National Comparative Audit of blood
transfusion practice will inform the design of the C-RCT
(WS2: Evaluation), by clearly describing the content of the
control and intervention conditions. The interventions
will be further informed by the feasibility and acceptability
component of WS1 (Intervention development and pilot-
ing). The extent to which fidelity is maintained in the con-
text of WS1 (Intervention development and piloting) will
provide an indicator of the extent to which the larger-
scale evaluation of these interventions will be feasible; if it
is demonstrated that fidelity cannot be maintained under
these ‘ideal,’ pilot conditions, it is unlikely that high fidelity
will be maintained in the context of a larger RCT in WS2
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(Evaluation). The larger scale fidelity study (WS3: Fidelity),
to be conducted in parallel will the C-RCTs, will compare
the delivery of the intervention against the intervention as
planned. Finally, the protocols developed for both inter-
ventions will facilitate the generalisation of these proto-
type enhancements to wider contexts outside of blood
transfusion (WS4: Implementation).
The workstream structure of the AFFINITIE Programme
directly reflects the UK MRC guidance on the development
of complex interventions. WS1 (Intervention development
and piloting) will apply a robust theoretical basis for inter-
vention design. Feasibility and acceptability will be system-
atically assessed before taking the interventions to formal
randomised evaluation. Evaluation of effectiveness, in terms
of outcomes, process, and cost effectiveness will be ad-
dressed in workstreams two (evaluation) and three (fi-
delity), with the final workstream four (implementation)
disseminating the findings with a view to generalising
the interventions beyond the blood transfusion context.
The multidisciplinary expertise from both behav-
ioural and clinical areas will inform the intervention
(the AFFINITIE research team includes haematologists,
trialists, health psychologists, social scientists, statisticians,
health economist,s and patient representatives). This is fur-
ther strengthened through the contribution of the PPI panel.
The methods for intervention development described
in this protocol nonetheless have a range of limitations.
First, current practice is always improving and there is
no guarantee that the specification of usual feedback
practice based on past A&F cycles will precisely describe
the control conditions in the proposed trials. Hence, the
planned fidelity study will examine the control interven-
tions as well as the enhanced interventions. Second,
even if the enhanced interventions are feasible to deliver
in the context of clinical practice, they may not be feas-
ible to deliver in the context of a time-constrained trial.
Hence, there will be some constraints on intervention
design. Finally, although we will attempt to recruit di-
verse samples of hospitals for study B (delivery) and
study C (feasibility and acceptability), it is possible that
staff in hospitals that are willing to participate in these
stages of the study will place transfusion practice higher
on their agenda than other English hospitals. Of note is
that fact that hospitals participating in study C (feasibil-
ity and acceptability) will not be eligible to participate in
the trials (as they will receive the enhanced interven-
tions in order to provide data about feasibility and ac-
ceptability). Hence, it is possible that the feasibility and
acceptability data will not be fully representative of all
English hospitals. We accept these limitations as neces-
sary restrictions, given the importance of checking feasi-
bility and acceptability prior to full evaluation.
We believe that the methods presented in this paper dem-
onstrate a theoretically robust, evidence-based, consultative
model of research as an example of good practice for inter-
vention development and we offer these methods to the
research community with a view to sharing good practice
in the design of complex implementation interventions.
Additional files
Additional file 1: An example of a current feedback report.
Additional file 2: Potential enhancement of feedback content.
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